U.S. House Financial Services Committee Discusses Over-the-Counter Derivatives Reform
Oct 7, 2009
The United States House Financial Services Committee held a hearing entitled “Reform of the Over-the-Counter (“OTC”) Derivative Market: Limiting Risk and Ensuring Fairness” on Wednesday, October 7 at 10:00 a.m. To view an archived webcast of this hearing, click here.
To view draft legislation to regulate OTC derivatives circulated by House Financial Services Committee Chairman Barney Frank, click here.
A list of witnesses and corresponding hyperlinks to their testimony is reprinted below.
Witnesses
Panel one
- Gary Gensler, Chairman, Commodity Futures Trading Commission
- Henry Hu, Director, Division of Risk, Strategy, and Financial Innovation, U.S. Securities and Exchange Commission
Panel two
- Jon Hixson, Director, Federal Government Relations, Cargill, Incorporated
- René M. Stulz, Everett D. Reese Chair of Banking and Monetary Economics, Fisher College of Business, The Ohio State University
- Scott Sleyster, Chartered Financial Analyst, Chief Investment Officer, Domestic, Prudential Financial
- David Hall, Chief Operating Officer, Chatham Financial Corporation
- James J. Hill, Managing Director, Morgan Stanley on behalf of SIFMA
- Stuart J. Kaswell, Executive Vice President and Managing Director, General Counsel, Managed Funds Association
- Steven A. Holmes, Director of Treasury Operations, Treasury Department, Deere and Company World Headquarters
- Christopher Ferreri, Managing Director, ICAP on behalf of the Wholesale Markets Brokers Association
- Rob Johnson, Director of Economic Policy for the Roosevelt Institute in New York on behalf of Americans for Financial Reform
Should you have any questions or comments, please contact Colodny Fass.
To unsubscribe from this newsletter, please send an e-mail to ccochran@cftlaw.com